Unit of drugmaker Insys to plead guilty to U.S. opioid bribe scheme

A unit of Insys Therapeutics Inc is set to plead guilty on Friday to fraud charges as part of an $225 million deal with the U.S. Justice Department resolving claims that the drugmaker bribed doctors to prescribe an addictive opioid medication.